Alnylam’s RNAi Therapy for Acute Hepatic Porphyria Positive in Phase III

Press/Media

Period	15 Apr 2019

Media coverage

Title	Alnylam’s RNAi Therapy for Acute Hepatic Porphyria Positive in Phase III
Media name/outlet	Pharma Live
Country/Territory	United States
Date	15/04/19
URL	https://www.pharmalive.com/alnylams-rnai-therapy-for-acute-hepatic-porphyria-positive-in-phase-iii/
Persons	Manisha Balwani